Insights from the Greek experience of the use of Blinatumomab in pediatric relapsed and refractory acute lymphoblastic leukemia patients.
暂无分享，去创建一个
G. Paterakis | V. Kitra | G. Avgerinou | A. Kattamis | M. Tzanoudaki | M. Baka | V. Papadakis | D. Doganis | S. Polychronopoulou | M. Ampatzidou | T. Anastasiou | A. Kaisari